| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 02/11/2009 | EP2021327A2 Antidiabetic bicyclic compounds |
| 02/11/2009 | EP2021314A1 Substituted biphenyl carboxylic acids and derivatives thereof |
| 02/11/2009 | EP2021015A2 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 02/11/2009 | CN101365439A Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 02/11/2009 | CN101362705A 3,5-diaminobenzoic acid preparation method |
| 02/11/2009 | CN101362704A N-(4-fluorophenyl)-N-(2-carboxy-4-chlorophenyl) glycine preparation method |
| 02/11/2009 | CN101362703A P-hydroxybenzene glycine synthesis technology |
| 02/11/2009 | CN101362696A New preparation method of 3-aminomethyl-5-methyl butylacetic acic |
| 02/11/2009 | CN100460383C Compound and preparation method thereof and application in pharmacy |
| 02/11/2009 | CN100460382C Novel method for synthesizing esters of N-[(S)-1-carboxybutyl]-(S)-alanine and use thereof for synthesizing perindopril |
| 02/10/2009 | US7488844 Therapeutic agents |
| 02/10/2009 | US7488841 Composition containing acyl group |
| 02/10/2009 | US7488840 Method for producing 2-chloromethylphenyl acetic acid derivatives |
| 02/10/2009 | US7488758 Levalbuterol hydrochloride polymorph B |
| 02/10/2009 | US7488755 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
| 02/10/2009 | CA2336691C Ligands for metals and metal-catalyzed processes |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2211270C Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 02/05/2009 | WO2009018389A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | WO2009017056A1 Compound, method for producing the same, ink composition using the compound, thin film, organic transistor, and organic electroluminescent device |
| 02/05/2009 | WO2009016879A1 Method of producing optically active n-(halopropyl)amino acid derivative |
| 02/05/2009 | WO2009016235A2 Chelating agent based ionic liquids, a process to prepare them, and their use |
| 02/05/2009 | WO2009016025A1 Process for the synthesis of na- beta-alaninate and calcium pantothenate |
| 02/05/2009 | WO2009015685A1 Method for preparing polymorph form ii of gabapentin |
| 02/05/2009 | WO2009015560A1 Use of allylcysteine or its analogs and pharmaceutical composition threrof |
| 02/05/2009 | US20090036708 Novel Process for the Preparation of Nonracemic Long Chain alpha-Amino Acid Derivatives |
| 02/05/2009 | US20090036673 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes |
| 02/05/2009 | US20090036576 Cyanophycin Production From Nitrogen-Containing Chemicals Obtained From Biomass |
| 02/05/2009 | US20090036526 Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate |
| 02/05/2009 | US20090036525 Non-Natural Amino Acid Derivatives |
| 02/05/2009 | US20090036523 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | US20090036311 Benzoyl-Substituted Alanines |
| 02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
| 02/05/2009 | DE10348674B4 Racemisierung von optisch aktiven 2-substituierten Phenylglycinestern Racemization of optically active 2-substituted Phenylglycinestern |
| 02/05/2009 | CA2694325A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/04/2009 | EP2019817A2 Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
| 02/04/2009 | EP2019673A2 Compounds for the treatment of metabolic disorders |
| 02/04/2009 | CN100457719C Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 02/04/2009 | CN100457715C Process for the hydrogenation of aromatic compounds |
| 02/04/2009 | CN100457708C Interfacial method of preparing ester-substituted diaryl carbonates |
| 02/03/2009 | US7485742 Non-glycosidic and non-peptidic inhibitors of selectin, and the use thereof |
| 02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
| 02/03/2009 | CA2412055C Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 01/29/2009 | WO2009014177A1 Method for selective removal of dibenzofulvene derivative |
| 01/29/2009 | WO2009013539A1 Composition |
| 01/29/2009 | WO2009013534A1 Composition |
| 01/29/2009 | WO2008107211A3 Novel p2y12 receptor antagonists |
| 01/29/2009 | US20090030226 Process For Preparing Aminobenzoate Esters |
| 01/29/2009 | US20090030218 Method For Producing Aminoalcohol Derivative Having Biphenyl Group |
| 01/29/2009 | US20090030082 SYNTHETIC LIGANDS SELECTIVE FOR LXRbeta OVER LXRalpha, IDENTIFICATION AND METHODS OF USE THEREOF |
| 01/29/2009 | US20090030080 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 01/29/2009 | US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds |
| 01/29/2009 | US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors |
| 01/29/2009 | US20090029099 Fluorine-containing monomer, fluorine-containing polymer and surface treating agent |
| 01/29/2009 | CA2689129A1 Composition |
| 01/29/2009 | CA2688561A1 Composition |
| 01/28/2009 | CN101353312A Phenylglycine derivatives synthesis |
| 01/28/2009 | CN101353311A Process for preparing aminobenzoate esters |
| 01/27/2009 | US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 01/27/2009 | US7482489 Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof |
| 01/27/2009 | US7482484 Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 01/27/2009 | US7482483 calixarenes having acyclic isophthalic acid groups attached, used as target for platelet derived growth factors or vascular endothelial growth factors; angiogenesis inhibitors, antiproliferative, antitumor or anticarcinogenic agents |
| 01/27/2009 | CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
| 01/22/2009 | WO2009010554A1 Process for the enantioselective preparation of pregabalin |
| 01/22/2009 | US20090023953 Pentafluorosulfanyl containing amino acids |
| 01/22/2009 | US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/22/2009 | US20090023786 Histone Deacetylase Inhibitor Prodrugs |
| 01/22/2009 | US20090023734 Treating cell proliferative disorders |
| 01/22/2009 | CA2693843A1 Process for the enantioselective preparation of pregabalin |
| 01/21/2009 | EP2017273A1 Process for the enantioselective preparation of pregabalin |
| 01/21/2009 | EP2017259A2 Preparation of gamma-amino acids having affinity for the alpha-2-delta protein |
| 01/21/2009 | EP2017258A1 Process for production of radioactive fluorine-labeled organic compound |
| 01/21/2009 | EP2017244A2 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion |
| 01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/15/2009 | WO2009009287A2 Hormone sensitive lipase modulators and methods of use |
| 01/15/2009 | WO2009008997A2 Treatment of neuropathic pain |
| 01/15/2009 | WO2009008491A1 Diamine compound, polyamic acid, soluble polyimide, composition, wettability changing film, electrode, and method of manufacturing a wettability changing film |
| 01/15/2009 | WO2009007230A1 Use of nitric oxide releasing compounds in the treatment of chronic pain |
| 01/15/2009 | WO2008062460A3 Crystalline forms of pregabalin |
| 01/15/2009 | US20090018311 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 01/15/2009 | US20090018191 Deuterated Catecholamine Derivatives and Medicaments Comprising Said Compounds |
| 01/15/2009 | US20090018189 Hormone Sensitive Lipase Modulators And Methods Of Use |
| 01/15/2009 | US20090018145 Compositions and their use as anti-tumor agents |
| 01/15/2009 | US20090017545 Method of Determining Metal by Colorimetry and Determination Reagent |
| 01/15/2009 | US20090017509 Method for the production of ramipril |
| 01/15/2009 | US20090017307 Process for the Preparation of Organic Materials |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | DE112007000484T5 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins |
| 01/15/2009 | DE102004062640B4 Verfahren zur Synthese 2-arylsubstituierter beta-Aminosäurederivate Method for the synthesis of 2-aryl-substituted beta-amino acid derivatives |
| 01/15/2009 | DE10148682B4 Verfahren zur Herstellung von ω-Aminoalkansäuren und deren Alkalimetallsalzen Process for the preparation of ω-aminoalkanoic acids and their alkali metal salts |
| 01/15/2009 | CA2692805A1 Use of nitric oxide releasing compounds in the treatment of chronic pain |
| 01/14/2009 | EP2013161A1 Process for the deprotection of protected amines |
| 01/14/2009 | EP2012770A2 Trivalent chromium compounds, compositions and methods of use |
| 01/14/2009 | EP1556336B1 Metal complexes of alpha amino dicarboxylic acids |
| 01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
| 01/14/2009 | EP1131337B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 01/14/2009 | CN101346347A Method for production of phosphate salt of amino acid |
| 01/14/2009 | CN101346342A Photocrosslinkable materials |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |